Maple Leaf Green World Inc. (NEO:MGW) Vice President of Business Development Jameson Welbourn was interviewed by Business View Magazine. In the interview, he provided an update on the construction of their British Columbia, Nevada and California facilities. He also believes that the medical cannabis industry has long-term growth potential and can provide numerous health benefits for those wanting to use traditional plant-based medicines.
“It will make a huge impact, with the potential to change the way we think about medicine and health. Societal and cultural norms are shifting toward more traditional plant-based medicines and exploring these options before going to synthetic pharmaceuticals. I believe cannabis has tremendously far reaching medical applications,” said Welbourn.
Welbourn also believes that the future of the cannabis industry lies in extractions, especially when it comes down to medical cannabis. He talked about the process of isolating cannabinoids and how they can be used to treat a variety of ailments, such as anxiety, as more studies are conducted into the medical applications of the plant.
“There are massive benefits in treatment, prevention, and lifestyle aspects, and we’re excited about working with different groups to help people understand that it goes far beyond simply getting intoxicated,” said Welbourn. “Cannabis and cannabis derived products can really make a healthy difference in your daily life.”
To view the full interview, click here.
Both locations expand access to the state’s widest-ranging inventory of medical cannabis products for Central Florida patients
Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of two brand-new Central Florida dispensaries. The new Clearwater and Tampa locations mark the Company’s 81 st and 82 nd nationwide, respectively, widening patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.
Philip Young, CEO and Director of Lobe, stated, “We are honored to welcome Bart to our Advisory Board. His first-hand experience on and off the field are tremendously valuable as we continue our research involving mild traumatic brain injuries and PTSD. These issues are prevalent in contact sports and we believe that athletes will play a prominent role in the continued acceptance of psychedelic medicines as legitimate treatment. We look forward to working with Bart as we seek to forge long-term strategic relationships.”
HempFusion Wellness Submits Novel Foods Dossier to the United Kingdom’s Regulatory Food Safety Agency
HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that it has submitted its dossier to the United Kingdom’s Regulatory Food Safety Agency (the “FSA”).
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210303005322/en/